SCHEMBL2408508

SCHEMBL2408508

NS(=O)(=O)S(N)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfamide SCHEMBL5880 0.77
SCHEMBL28603973 0.76
SCHEMBL5359490 0.76 CA1 (0.50)
SCHEMBL7247944 0.72
SCHEMBL29387950 0.72 CA1 (0.46)
SCHEMBL947781 0.72
SCHEMBL28647963 0.72
SCHEMBL9354352 0.72
SCHEMBL18166817 0.72 CA1 (0.46)
SCHEMBL4236544 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150133450-A1 METHODS AND COMPOSITIONS USEFUL FOR TREATING DISEASES INVOLVING BCL-2 FAMILY PROTEINS WITH QUINOLINE DERIVATIVES EUTROPICS PHARMACEUTICALS INC (US) 2015-05-14 US claimed
CN-1358178-A Pharmaceutical compounds NICOX SA (FR) 2002-07-10 CN claimed
US-5932402-A ORGANIC YELLOW PYRAZOLONE AND/OR SULFONAMIDE DYE THAT CAN BE DECOLORIZED DURING PROCESSING AGFA-GEVAERT AG (DE) 1999-08-03 US claimed
CN-112004808-A Prodrugs of NRF 2-activating compounds and uses thereof 参宿七制药股份有限公司 2020-11-27 CN disclosed
CN-111356764-A Compositions and methods for lowering serum cholesterol and PCSK9 卡斯西部储备大学 2020-06-30 CN disclosed
EP-3106453-B1 METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND, AND NOVEL METAL-DIAMINE COMPLEX TAKASAGO PERFUMERY CO LTD (JP) 2020-04-08 EP disclosed
US-9745229-B2 Method for producing optically active compound, and novel metal-diamine complex TAKASAGO INTERNATIONAL CORPORATION (JP) 2017-08-29 US disclosed
EP-3106453-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND, AND NOVEL METAL-DIAMINE COMPLEX Takasago International Corporation (JP) 2016-12-21 EP disclosed
US-20160347678-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND, AND NOVEL METAL-DIAMINE COMPLEX TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-12-01 US disclosed
CN-106145157-A A kind of processing technique of sulphamide 安徽兴东化工有限公司 2016-11-23 CN disclosed
EP-2738200-B1 Boronated polyphosphinohydrazide fire retardant BOEING CO (US) 2015-09-16 EP disclosed
WO-2007109334-A2 SIP RECEPTOR MODULATING COMPOUNDS AND USE THEREOF EPIX DELAWARE, INC. (US) 2007-09-27 WO disclosed
US-20070186808-A1 CYAN INK FOR INK-JET RECORDING BROTHER KOGYO KABUSHIKI KAISHA (JP) 2007-08-16 US disclosed
US-20070186806-A1 Ink Set for Ink-Jet Recording BROTHER KOGYO KABUSHIKI KAISHA (JP) 2007-08-16 US disclosed
US-20070186811-A1 INK FOR INK-JET RECORDING BROTHER KOGYO KABUSHIKI KAISHA (JP) 2007-08-16 US disclosed
CN-1923797-A Pharmaceutical compounds NICOX SA (FR) 2007-03-07 CN disclosed
US-6667342-B1 Elevation of pyruvate dehydrogenase activity ASTRAZENECA AB (SE) 2003-12-23 US disclosed
CN-1358178-A Pharmaceutical compounds NICOX SA (FR) 2002-07-10 CN disclosed
EP-1064274-A1 BENZENESULFONAMIDE DERIVATIVES AND THEIR USE AS MEDICAMENTS AstraZeneca AB (SE) 2001-01-03 EP disclosed
WO-1999047508-A1 BENZENESULFONAMIDE-DERIVATIVES AND THEIR USE AS MEDICAMENTS ASTRAZENECA AB (SE) 1999-09-23 WO disclosed